HomeFileCoronary disease

Coronary disease

View Category

ACC 2017 HIGHLIGHTS

Infarction in Cariogenic Shock: Prioritizing the Use of Impella Could Improve Survival

This small study suggests the early use of Impella ventricular support device in patients undergoing AMI complicated...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

FFR-Guided ACS Revascularization Apparently Superior to Culprit Vessel Treatment

Using fractional flow reserve (FFR) to guide revascularization of all functionally significant lesions in the setting of...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

Higher Radiation Dose in Patients and Operators with Radial Approach (RAD-MATRIX Dosimeter)

Both physicians and patients are exposed to higher radiation doses during radial access PCI compared to femoral,...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

DECISION-CTO: Prevailing Questions on CTO Rechanneling

The first and only randomized trial on chronic total occlusion (CTO) revascularization versus optimal medical therapy in...
solaci -
Learn More
ACC 2017 HIGHLIGHTS

ABSORB III: More Events with Absorb Than With Xience at Two Years

The two year outcomes of ABSORB III, presented at the scientific sessions of the American College of...
solaci -
Learn More
Acute coronary syndromes

Pregnancy and Risk of Spontaneous Coronary Artery Dissection: How to Proceed

Courtesy of Dr. Pablo Baglioni. Between the years 2000 and 2015, the authors of this article searched for...
solaci -
Learn More
Coronary disease

SYNERGY vs. XIENCE in Complex Real-World Patients

Courtesy of Dr. Guillermo Migliaro. Technological advancements in drug-eluting stents (DES) have shown significant improvement as regards the...
solaci -
Learn More
Coronary disease

Biolimus and Everolimus Eluting Stents in Coronary Artery Disease: Similar Safety?

Courtesy of Dr. Guillermo Migliaro. Events such as very late stent thrombosis and restenosis after first generation DES...
solaci -
Learn More